About this episode

The episode discusses the FDA approval of Afrezza inhaled insulin for children with type 1 diabetes, featuring insights from medical professionals and a patient family.

In this episode of the TCOYD Podcast, Dr. Steve Edelman is joined by pediatric endocrinologist Dr. Anna Cymbaluk, along with Philip and his father Jim, to discuss the recent FDA approval of Afrezza inhaled insulin for children and adolescents living with type 1 diabetes. Dr. Cymbaluk served as an investigator on the INHALE-1 trial, while Philip participated in the study himself, providing a unique real-world perspective on what it is like to transition from injections to inhaled insulin , and Philip’s dad, Jim provided the parent perspective as well as addressed parental concerns that might have arisen. The conversation focuses on the INHALE-1 study and the unmet challenges that continue to exist around mealtime insulin dosing in pediatric diabetes care. Dr. Cymbaluk reviews the trial design, glucose outcomes, safety data, patient satisfaction findings, and the practical realities of introducing inhaled insulin into everyday diabetes management. Philip and Jim share how Afrezza impacted school, sports, social situations, and the day-to-day burden of diabetes, particularly around pre-bolusing, corrections, and avoiding multiple injections throughout the day. Dr. Edelman and Dr…

More episodes of Taking Control Of Your Diabetes® - The Podcast!

• Raising Kids with Type 1 Diabetes: Practical Advice Every Parent Needs with Raquel Baron · July 14, 2026 · 33 min
• Inhaled Insulin for Kids: Inside the INHALE-1 Trial · June 15, 2026 · 45 min

Explore listener stats, chart rankings, contacts and more on the Taking Control Of Your Diabetes® - The Podcast! podcast page.